FLAT RATE SHIPPING OF $9.95 AUSTRALIAN WIDE
FREE SHIPPING FOR ORDERS OVER $99
Need help? Call us on (07) 5532 2069

Panaxea RE:Focus 60Caps

offer-img-alt
Practitioner-Only Product

Panaxea RE:Focus 60Caps

POS-165595

Price

profile-img

Our Naturopaths Say

RE:FOCUS combines traditional herbal medicines with targeted botanical compounds that may help regulate neurotransmitter pathways involved in attention and mental performance. It is commonly used in integrative protocols supporting ADHD-type presentations, hyperactivity, and concentration difficulties.

Description

Re:Focus is the latest development in botanical treatments for ADHD. It combines whole botanicals with molecular extracts of scientifically studied compounds that target the neurotransmitter pathways.

Re:Focus contains Gastrodin, a major compound found in Gastrodia elata that research shows exerts significant antiADHD effects.

Indications: Hyperactivity ADHD and Attention deficit disorder ADD.

Actions of ingredients:

* anti-inflammatory; down regulates TNF, IL6

* Regulation of monoamine neurotransmitters

* Antioxidation

* Anti-anxiety

* Neuron protection

Ingredients

  • Ophiopogon japonicus 60mg
  • Paeonia lactiflora 35mg
  • Ziziphus jujuba 60mg
  • Coptis chinensis 12.5mg
  • Polygala tenuifolia 35mg
  • Phellodendron amurense 12.5mg
  • Anemone altaica 35mg
  • Gastrodia elata 250mg

Details

Cautions and Contraindications:

CYP450 Gastrodin might reduce the metabolic rate of CYP450-metabolized therapeutic drugs for ADHD, and the combination of gastrodin with these drugs might have a synergistic effect. CYP1A1 is an important paralog of CYP1A2, both of which are members of the cytochrome P450 (CYP450) superfamily. AMP, atomoxetine, and tricyclic antidepressants, commonly used in ADHD treatment, are metabolized by CYP1A2, but their relationship with CYP1A1 has not been reported. Our results suggested that gastrodin might down-regulate CYP1A1 expression. It was speculated that a beneficial interaction existed between the CYP450-metabolized therapeutic drugs for ADHD and gastrodin.

Specifically, gastrodin might reduce the metabolic rate of these drugs in vivo by inhibiting CYP1A1 activity, thereby improving their efficacy (3).

Uses

2-3 Capsules daily.

Leave a Review

Only registered users can write reviews. Please, log in or register

Subscribe to Gr8Health

Sign up to get 5% off your first order, exclusive access to our special offers, new arrivals and more.

© 2026 Gr8 Health